Cargando…
Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings
Enzyme replacement therapy (ERT) is one of the available therapies for mucopolysaccharidosis (MPS). This study presents a follow-up of two siblings with MPS IVA (Morquio A disease) that received ERT. Both siblings received weekly intravenous infusions of elosulfase alfa for 4.5 years. One sibling (p...
Autores principales: | Barak, Sharon, Anikster, Yair, Sarouk, Ifat, Stern, Eve, Eisenstein, Etzyona, Yissar, Tamar, Sherr-Lurie, Nir, Raas-Rothschild, Annick, Guttman, Dafna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168314/ https://www.ncbi.nlm.nih.gov/pubmed/32079294 http://dx.doi.org/10.3390/diagnostics10020108 |
Ejemplares similares
-
Correction: Barak, S. et al. “Long-Term Outcomes of Early Enzyme Replacement Therapy for Mucopolysaccharidosis IV: Clinical Case Studies of Two Siblings”. Diagnostics 2020, 10, 108
por: Barak, Sharon, et al.
Publicado: (2020) -
Transition to Multidisciplinary Pediatric Telerehabilitation during the COVID-19 Pandemic: Strategy Development and Implementation
por: Krasovsky, Tal, et al.
Publicado: (2021) -
A Behavioral Characteristics Observational Measure of Youth with Somatic Symptom Disorder during Physical Rehabilitation
por: Barak, Sharon, et al.
Publicado: (2023) -
Pediatric Functional Neurological Symptoms Disorder: Walking Ability and Perceived Exertion Post-Pediatric Rehabilitation
por: Landa, Jana, et al.
Publicado: (2023) -
Biomarkers in patients with mucopolysaccharidosis type II and IV
por: Fujitsuka, Honoka, et al.
Publicado: (2019)